Related by context. Frequent words. (Click for all words.) 68 N methyl 68 humanized anti 68 hypoxia inducible factor 68 partial agonist 68 Panzem R 67 C1 esterase inhibitor 67 PRICE GREAT DISCOUNT FREE 67 CONTAINS FORWARD LOOKING STATEMENTS 67 Aurora kinase 66 CHEAP ONLINE PHARMACY LOW 66 WEB SITE OR 66 THAT COULD CAUSE ACTUAL 66 THAT ARE SUBJECT TO 66 CONTAIN FORWARD LOOKING STATEMENTS 66 CERTAIN RISKS AND UNCERTAINTIES 66 IS FOR INFORMATIONAL 66 RESULTS PERFORMANCE OR ACHIEVEMENTS 65 BY MARK CURNUTTE 65 SEE CONTINUED DOWNWARD MOMENTUM 65 Evo IX +# mins 65 Voreloxin 65 Pivotal Phase III 65 luteinizing hormone releasing 65 WE URGE INVESTORS 65 IT WILL CONTAIN 65 HAS BEEN PREPARED BY 65 RESULTS TO DIFFER 65 INFORMATION ABOUT THE PROPOSED 65 AND SHOULD ALSO 65 EXPRESSED OR IMPLIED 65 CHEAP ONLINE PHARMACY BEST 64 IS NOT AN OFFER 64 ANY RESPONSIBILITY FOR ANY 64 BECAUSE THEY WILL CONTAIN 64 SHALL NOT CONSTITUTE AN 64 BY JIM HAND 64 OFFER TO PURCHASE 64 #.#secs P 64 THE COMPANY 'S PERIODIC 64 INVESTORS ARE URGED TO 64 SX4 WRC +# mins 64 SUCH FORWARD LOOKING STATEMENTS 64 selective inhibitor 64 sphingosine 1 64 Drug Candidate 64 FGFR 64 liposomal formulation 63 Am J Clin 63 THE EXPRESSED WRITTEN CONSENT 63 Phase III Clinical Trial 63 PURSUANT TO THE 63 TRANSCONTINENTAL MEDIA 63 RISK FACTORS DISCLOSED IN 63 VERINT logo ACTIONABLE INTELLIGENCE 63 MEK inhibitor 63 THAN AN INVESTMENT 63 Completes Enrollment 63 CYC# 63 MADE BASED UPON 63 VERIFICATION OF THE 63 Isis# where 63 REPORTS FILED FROM 63 Preclinical Data 63 Pivotal Phase 63 BY SUCH STATEMENTS 63 OFFER TO SELL OR 63 THE TERMS AND CONDITIONS 63 Pivotal Trial 63 * LW# * 63 receptor agonist 63 BE ANY SALE 63 Vascular Endothelial Growth 62 Epratuzumab 62 WMDT #/#/# [001] 62 THE TENDER OFFER STATEMENT 62 THE PROPOSED TRANSACTION 62 BY JO ANN 62 WATCH FOR CONTINUED GAINS 62 ARE REASONABLE THERE CAN 62 STOCKHOLDERS ARE URGED TO 62 THEY WILL CONTAIN IMPORTANT 62 READ THE PROXY 62 FLT3 62 Bortezomib 62 BY DAVID LINTON 62 THE ACTUAL RESULTS 62 phase IIb clinical 62 ACTUAL RESULTS TO DIFFER 62 THEY BECOME AVAILABLE BECAUSE 62 mTOR inhibitor 62 fumarate 62 orally bioavailable 62 Traficet EN 62 irresponsible nuisances 62 Initiates Phase 62 SEATTLEPI.COM STAFF 62 RESIDENTIAL DWELLING OF 62 ARE NOT LIMITED 62 relapsed refractory multiple myeloma 62 ST PHOTO 62 potent inhibitor